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Abstract
Acute pancreatitis (AP) is acute inflammation of the pancreas, mainly caused by gallstones
and alcohol, driven by changes in communication between cells. Heparin-binding proteins
(HBPs) play a central role in health and diseases. Therefore, we used heparin affinity prote-
omics to identify extracellular HBPs in pancreas and plasma of normal mice and in a caeru-
lein mouse model of AP. Many new extracellular HBPs (360) were discovered in the
pancreas, taking the total number of HBPs known to 786. Extracellular pancreas HBPs form
highly interconnected protein-protein interaction networks in both normal pancreas (NP)
and AP. Thus, HBPs represent an important set of extracellular proteins with significant reg-
ulatory potential in the pancreas. HBPs in NP are associated with biological functions such
as molecular transport and cellular movement that underlie pancreatic homeostasis. How-
ever, in AP HBPs are associated with additional inflammatory processes such as acute
phase response signalling, complement activation and mitochondrial dysfunction, which
has a central role in the development of AP. Plasma HBPs in AP included known AP bio-
markers such as serum amyloid A, as well as emerging targets such as histone H2A. Other
HBPs such as alpha 2-HS glycoprotein (AHSG) and histidine-rich glycoprotein (HRG) need
further investigation for potential applications in the management of AP. Pancreas HBPs are
extracellular and so easily accessible and are potential drug targets in AP, whereas plasma
HBPs represent potential biomarkers for AP. Thus, their identification paves the way to
determine which HBPs may have potential applications in the management of AP.
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Introduction
The pancreas develops from endodermal cells in the foregut and has important exocrine and
endocrine functions [1]. Acute pancreatitis (AP) is acute inflammation of the pancreas and is
mainly caused by gallstones and alcohol [2]. It is a leading gastrointestinal cause of hospitaliza-
tion and has significant quality of life implications for the patient and cost implications for
health systems [3]. Although most episodes of AP are mild and self-limiting, the severe form of
the disease, accompanied by a systemic inflammatory response syndrome and multi-organ
failure, is associated with a high mortality. At a cellular level disruption of calcium signaling
and mitochondrial dysfunction have been implicated in the pathogenesis of AP [4, 5].
The clinical characteristics of AP suggest that an important molecular component is
changed in cell communication within the pancreas and, in severe AP, systemically between
the pancreas and other organs. Cell communication occurs between cells through the medium
of the extracellular matrix, with cell receptors responsible for generating the cellular response.
The importance of extracellular proteins in mediating communication between cells in multi-
cellular organisms is underscored by the demonstration that the increase in multicellular
organism complexity is accompanied by an expansion and increase in the complexity of extra-
cellular proteins [6]. A key non-protein component of the extracellular space is the glycosami-
noglycan heparan sulfate (HS), because it binds and regulates the activity of a large number of
extracellular proteins involved in cell communication ([7]; reviewed in [8]; [9]).
HS is formed of linear repeats of a disaccharide of 1,4 linked uronic acid (α-L-iduronate,
IdoA, or β-D-glucuronate, GlcA) and α-D-N-acetylglucosamine (GlcNAc), with variable O-
sulfation of C2 on the uronic acid, of C3 and C6 on the glucosamine; the glucosamine being
either N-acetylated or N-sulfated [8, 9]. These modifications are hierarchical [9, 10], resulting
in chains with a distinct domain structure [11]; heparin-binding proteins (HBPs) bind to the
sulfated domains and their flanking transition domains. HS chains are attached to proteins to
form proteoglycans (HSPGs), with the core proteins serving in part to direct chains to particu-
lar extracellular locations [9]. Heparin is often used as a proxy for the sulfated domains of HS,
though it is more homogenous and sulfated than these [8].
Many individual studies have demonstrated a variety of mechanisms whereby binding to
HS regulates the function of extracellular proteins, but only recently has this been analysed on
a global scale [7]. The latter work demonstrated that of the extracellular proteins, the HBPs
form a highly interconnected functional network through protein-protein interactions that are
linked to physiological and pathological processes in more complex multicellular organisms.
Along with the numerous studies on individual proteins, the HBPs have been demonstrated to
be important signalling molecules in the cellular microenvironment that influence fundamen-
tal biological processes in development, homeostasis and disease [7, 9, 12].
We previously used mRNA expression data as a proxy for protein to test the hypothesis that
HBPs, which are demonstrably functionally important at a genome-wide level [7], are equally
important in the context of a single organ, the pancreas, and its associated digestive diseases
[13]. This work showed that HBPs are indeed a key subclass of extracellular proteins, whose
pattern of expression differs in the healthy and diseased pancreas. However, this work has
compromises, since mRNA expression does not always correlate with protein expression [14–
16]. Moreover, the use of mRNA assumes that the existing set of 435 HBPs [7] is reasonably
representative of those expressed in pancreas and that this organ does not express novel HBPs.
From the perspective of pancreatic diseases, HBPs, because they bind to heparin and are extra-
cellular, represent easily accessible new targets for the development of drugs. However, from a
biomarker perspective, sampling pancreas HBPs would be invasive.
Heparin binding proteins in acute pancreatitis
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We have, therefore, undertaken a proteomic analysis of HBPs in the pancreas and plasma
of normal mouse and in the caerulein-induced mouse model of AP. We identified 360 extra-
cellular HBPs in pancreas that were not previously known to bind the polysaccharide. Analysis
of the protein-protein interactions of the extracellular pancreas and plasma HBPs demon-
strates that they are highly interconnected in NP and AP. Label-free quantification by mass
spectrometry identified a number of HBPs, including some known biomarkers of AP, such as
carboxypeptidases (CPB1 and CPB2) and pancreatic amylase (AMY2A) [17], which were over-
expressed in AP as compared to NP. Isolation of plasma HBPs by heparin affinity chromatog-
raphy resulted in a reduction of the high abundance protein albumin, so that it would not
interfere with mass spectrometry. Of the 151 plasma HBPs isolated, some were known bio-
markers of AP, such as serum amyloid A (SAA) while others were emerging novel markers
and drug targets in AP such as histone H2A. These may provide a route to applications in the
management of AP.
Methods
HBPs from pancreas
Pancreatic murine models. CD1 mice were used in all experiments, as they are geneti-
cally heterogeneous and more likely to represent the human population [18]. Pancreases were
obtained from 6–8 week old male adult CD1 mice (weight range, 24–30 g) with normal pan-
creas (NP) or experimental acute pancreatitis (AP). In order to induce experimental acute pan-
creatitis, CD1 mice were fasted for 12 hours before each experiment, following which they
were administered seven hourly intraperitoneal injections of caerulein (50 μg/kg; Sigma-
Aldrich, Gillingham UK) dissolved in 0.9% (w/v) saline (Braun Medical, Aylesbury, England).
Pancreatitis was confirmed in the experimental mice 24 hours after the first intraperitoneal
injection. All mice (NP and AP) were euthanized by cervical dislocation. Studies were con-
ducted in compliance with UK Home Office regulations (PL4003320), and were approved by
the Institutional ethical review Committee of the University of Liverpool.
A blood sample was collected for serum amylase determination. Serum amylase activity was
tested in the Clinical Biochemistry Department in Royal Liverpool University Hospital. A
sliver of pancreatic tissue from each of the pancreases was fixed in formalin for H&E staining
and histological examination. The pancreases were removed, weighed, pooled together and
placed in buffer H (10 mM HEPES pH 7.5, 5 mM MgCl2, 25 mM KCl, 0.25 M sucrose supple-
mented with Complete protease inhibitors cocktail, Roche Products Ltd, Welwyn Garden
City, UK) at 4˚C. Complete protease inhibitor was used in all experiments as it has been
shown to be particularly effective in experiments involving pancreatic tissue [19]. Sixteen CD1
mice were used for each HBP isolation experiment. Each experiment was performed three
times for NP and for AP.
Isolation of a plasma membrane enriched fraction. The isolation of the plasma mem-
brane from murine pancreases was performed as described [7], with minor modifications. All
the steps were performed on ice or at 4˚C. Briefly, mouse pancreases were minced and homog-
enised with buffer H using a 30 mL Potter-Elvehjem homogeniser (30–40 strokes). Subcellular
fractionation was performed using sequential steps of centrifugation. The homogenate was
centrifuged for 20 min at 1,000 g in a Sorvall centrifuge (SS-34 rotor, DuPont UK, Stevenage,
UK). The pellet was resuspended with buffer H, homogenised and centrifuged again. The two
supernatants were then combined (S1) and centrifuged for 20 min at 25,000 g. This superna-
tant was transferred to a fresh tube and the centrifugation repeated. The final supernatant (S2)
was centrifuged for 45 min at 135,000 g in a Sorvall Ultra Pro 80 ultracentrifuge (T.865.1
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rotor) to produce a microsomal pellet, which was washed with 8 mL of buffer H (W) by resus-
pension and centrifuged as above.
The final microsomal pellet was resuspended by homogenisation in a Dounce homogeniser
(5 mL) with 4 mL of 1.55 M sucrose in buffer H and placed on a 2 mL 2 M sucrose cushion in
a swing-bucket ultracentrifuge tube. It was then overlaid with 2.5 mL 1.33 M, 2 mL 1.2 M, 2
mL 1.1 M, 1 mL 0.77 M and 1 mL 0.25 M sucrose, all in buffer H. The sucrose gradient was
centrifuged for 16 h at 116,000 g in a Sorvall Ultra Pro 80 ultracentrifuge (AH-629 rotor). Pur-
denz (GENTAUR Ltd, London, UK) was pumped into the bottom of the tube using a 20 mL
syringe to collect 1 mL fractions (F1-F12) from the top of the sucrose gradient. The first eleven
fractions (F1-F11) were diluted eight times with buffer H and centrifuged for 45 min at
135,000 g. The last fraction was discarded. The pellets thus obtained (P2-P11) were resus-
pended with 400 μL 2% (v/v) Triton X-100 (Sigma Aldrich) in phosphate-buffered saline (PBS;
10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl and 2.7 mM KCl, pH 7.4) using a Dounce
homogeniser (1 mL). Protein concentration was measured by the bicinchoninic acid (BCA)
protein assay (Pierce, Thermo Fisher Scientific, Northumberland, UK) in 1:20 dilutions of the
resuspended pellets (final Triton X-100 concentration: 0.1% (v/v)). Equal amounts of the
resuspended pellets P1-P11 were analysed by SDS-PAGE and by western blot, using a poly-
clonal antibody to caveolin1 (sc-890, Santa Cruz Biotechnology Inc., Insight Biotechnology,
Wembley, UK). After gel electrophoresis, samples were transferred to Hybond nitrocellulose
membrane (GE Healthcare Life Sciences, Buckinghamshire, UK) using a wet system (Mini
Trans-Blot Cell, Bio-Rad Laboratories Ltd Hemel Hempstead, Hertfordshire, UK) for 1 h at
100 V. Membranes were blocked with Tris-buffered saline (TBS) (20 mM Tris-Cl, 150 mM
NaCl, pH 7.5) supplemented with 10% (w/v) skimmed milk powder for 1 h at room tempera-
ture. The membranes were then incubated in TBST-1% (w/v) milk (TBS supplemented with
0.1% (v/v) Tween 20 (TBST) and 1% (w/v) skimmed milk powder) with rabbit anti-caveolin1
(1:200) overnight at 4˚C. After three 5 min washes with TBST, the membranes were incubated
in TBST-5% w/v milk (TBST supplemented with 5% (w/v) skimmed milk powder) with anti-
rabbit-HRP secondary antibody (A0545, Sigma Aldrich) (1:5,000) for 1 h at room temperature.
After at least three 5 min washes with TBST, the membranes were developed using the Super-
Signal West Pico Chemiluminescent substrate (Pierce, Thermo Fisher Scientific, Northumber-
land, UK).
Heparin affinity chromatography. Membrane pellets P2-P4 were selected according to
their sedimentation profile and caveolin-1 immunoreactivity. The resuspended pellets were
pooled, adjusted to 0.15 M NaCl and 1% (v/v) Triton X-100 and were applied to a 1 mL Hi-
Trap heparin column (GE Healthcare Life Sciences, capacity of 3 mg/mL antithrombin III)
equilibrated with a modified phosphate-buffered saline (PBS), buffer WL (0.15 M NaCl, 13.7
mM Na2HPO4, 6.3 mM NaH2PO4, 0.1% (v/v) Triton X-100, pH 7.2). After loading, the col-
umn was extensively washed with buffer WL until the absorbance at 280 nm reached the base-
line. Bound proteins were then eluted with a single column volume of buffer E (2 M NaCl, 13.7
mM Na2HPO4, 6.3 mM Na2HPO4, 0.1% (v/v) Triton X-100, pH 7.2). Protein was measured by
the BCA protein assay and was between 70 μg and 510 μg.
Sample preparation for mass spectrometry. Trichloroacetic acid (TCA, 70% w/v) was
added to an equal volume of the heparin-bound fraction and kept at -20˚C for 1 hour, followed
by centrifugation at 14,000 rpm for 10 minutes. After removing the supernatant fraction care-
fully with a glass pipette, the pellet was washed 5 times with 5% (w/v) TCA. The pellet was
freeze-dried overnight, washed subsequently with 0.5 mL diethyl ether to remove the excess
TCA and centrifuged at 5,000 rpm. The supernatant was removed and the diethyl ether wash
was repeated two more times. The final pellet was left to dry in the fume hood. The ether-
washed, TCA-precipitated pellets were resolublised in either 200 μL (normal pancreas (NP))
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or 600 μL (acute pancreas (AP)) 50 mM ammonium bicarbonate, 0.05% (w/v) Rapigest
(Waters, Manchester) and shaken at 550 rpm for 10 min at 80˚C. The sample was then reduced
(addition of 10 μL (NP) or 30 μL (AP) of 60 mM DTT and incubation at 60˚C for 10 min) and
alkylated (addition of 10 μL (NP) or 30 μL (AP) of 180 mM iodoacetamide and incubation at
room temperature for 30 min in the dark). Trypsin (Sigma, Poole, UK, proteomics grade) was
reconstituted in 50 mM acetic acid to a concentration of 0.2 μg/μL and 10 μL (NP) or 30 μL
(AP) added to the sample followed by overnight incubation at 37˚C. The digestion was termi-
nated and RapiGest was removed by acidification with the addition of 3 μL (NP) or 9 μL (AP)
of 100% v/v trifluoroacetic acid (TFA) and incubation at 37˚C for 45 min) and centrifugation
(15,000 × g for 15 min). To check for completeness of digestion each sample was analysed pre-
and post-acidification by SDS-PAGE.
Mass spectrometry data acquisition and analysis. For LC-MS/MS analysis each digest
was diluted to 250 ng/μL with 97/3/0.1% (v/v) water/acetonitrile/formic acid and mixed 2:1
with a protein digest standard (50 fmol/μL yeast alcohol dehydrogenase, Mass PREP Digestion
Standard, Waters). A 3 μL injection of this mixture, corresponding to 500 ng of sample and 50
fmol of standard was analysed using an Ultimate 3000 RSLC nano system (Thermo Scientific,
Hemel Hempstead, U.K.) coupled to a QExactive mass spectrometer (Thermo Scientific). The
sample was loaded onto the trapping column (Thermo Scientific, PepMap100, C18, 300 μm X
5 mm), using partial loop injection, for 7 min at a flow rate of 4 μL/min with 0.1% (v/v) TFA.
The sample was resolved on the analytical column (Easy-Spray C18 75 μm × 500 mm 2 μm col-
umn) using a gradient of 97% A (0.1% formic acid) 3% B (99.9% acetonitrile, 0.1% formic
acid) to 60% A 40% B (all v/v) over 90 minutes at a flow rate of 300 nL/min. The data-depen-
dent program used for data acquisition consisted of a 70,000 resolution full-scan MS scan
(automatic gain control (AGC) set to 1e6 ions with a maximum fill time of 250 ms) and the 10
most abundant peaks were selected for MS/MS using a 17,000 resolution scan (AGC set to 5e4
ions with a maximum fill time of 250 ms) with an ion selection window of 3 m/z and a normal-
ised collision energy of 30. To avoid repeated selection of peptides for MS/MS, the program
used a 30 second dynamic exclusion window. The data were processed with Progenesis QI
(version 2 Nonlinear Dynamics, Newcastle upon Tyne, UK). Samples were aligned according
to retention time using a combination of manual and automatic alignment. Default peak pick-
ing parameters were applied and features associated with a peptide ID (charges from 1+ to 4+
in this case) and with three or more isotope peaks were retained. Database searching was per-
formed using Mascot (Matrix Science, London, UK). A Mascot Generic File, created by Pro-
genesis QI, was searched against the reviewed entries of the reference proteome set of M.
musculus from Uniprot (19/02/2014, 43238 sequences) with the sequence of yeast alcohol
dehydrogenase (UniProt: P00330) added. A fixed carbamidomethyl modification for cysteine
and variable oxidation modification for methionine were specified. A precursor mass tolerance
of 10 ppm and a fragment ion mass tolerance of 0.01 Da were applied. The results were then
filtered to obtain a peptide false discovery rate (FDR) of 1% and further refinement of two pep-
tides per protein was applied. Label-free quantification was performed following the “Top3”
methodology [20] by the spiking of the sample prior to analysis with the internal standard of
50 fmol yeast alcohol dehydrogenase digest (Uniprot P00330, Waters). Proteins were anno-
tated as differentially expressed if they achieved a FDR corrected q value of 1%. Additionally,
an adjusted threshold p value of less than 0.001 following the Bonferroni correction was used
to identify the HBPs as potential biomarkers [21].
Identification of extracellular HBPs in NP and AP. Extracellular proteins were identi-
fied using a combination of bioinformatics tools. SignalP 4.1, which predicts the presence of a
secretory signal peptide, was used to identify extracellular proteins [22] with Phobius, which is
a combined transmembrane topology and signal peptide prediction tool, to obtain a wider
Heparin binding proteins in acute pancreatitis
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coverage for extracellular protein identification [23]. A third tool, SecretomeP 2.0, was used to
produce ab initio predictions of protein secretion not based on a secretory signal peptide [24].
A fourth tool QIAGEN’s Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, www.
qiagen.com/ingenuity), was used to identify extracellular and plasma membrane proteins. The
HBPs that were not identified using SignalP, Phobius, or SecretomeP, but which were identi-
fied using IPA were further investigated using a manual approach. In addition, candidate
HBPs identified by SignalP, Phobius or SecretomeP that were classified as not being extracellu-
lar using IPA were further examined using a manual approach. Each candidate HBP was
examined using UniProtKB [25] for the presence of an extracellular signature. The outputs of
the various approaches were merged to obtain the complete list of HBPs in NP and AP.
Interactions and construction of networks of HBPs. Interactions between HBPs were
obtained from the online database resource ‘Search Tool for the Retrieval of Interacting Genes’
(STRING). STRING 10.5 is a database of known and predicted functional interactions and
served as a ‘one-stop’ comprehensive resource for network creation and analysis [26]. The
interactions in STRING are provided with a probabilistic confidence score that is an estimate
of how likely an interaction describes a functional linkage between two proteins. A higher
score indicating a higher confidence is attributed when more than one type of information
supports a given association. Only interactions with a high confidence score (0.70 and above)
were used to build HBP networks in NP and AP. The resulting networks were termed ‘protein
interactomes’. A network is deemed to be well connected if its average clustering coefficient is
significantly higher than that of its corresponding random networks [27].
Functional analyses of extracellular pancreas HBPs in NP and AP. Canonical pathways
and bio-functions analyses—Canonical pathways are well-characterized signalling pathways
that have been curated from original data. Bio-functions are molecular and cellular functions
that play important roles in homeostasis in health and disease. The significance of the associa-
tion between the datasets and the canonical pathway/bio-function was measured by calculating
the p-value using Fisher’s exact test to determine the probability of the association between the
HBPs in the dataset and the canonical pathway/bio-function. Canonical pathways and bio-
function analyses are useful tools for the identification of potential biomarkers and drug tar-
gets. These were undertaken using IPA. They also help identify biological pathways that play
important roles in homeostasis and complex diseases.
Plasma HBPs
This method is deposited at protocols.io (dx.doi.org/10.17504/protocols.io.wdtfa6n).
Sample collection. Blood obtained from 6–8 week old male adult CD1 mice (weight
range, 24–30 g) with normal pancreas (NP) or experimental acute pancreatitis (AP), induced
as described above, was collected in 0.38% (w/v) sodium citrate (Sigma-Aldrich, Gillingham,
UK) and centrifuged at 5,000 × g at 4˚C for 15 min [28]. Supernatant plasma was extracted
and frozen at -20˚C.
Heparin affinity chromatography. The frozen murine plasma was defrosted on ice and
centrifuged at 16,100 × g for 10 min, at 4˚C. The resulting supernatant was diluted (1:8) in 75
mM NaCl, 6.85 mM Na2HPO4, 3.15 mM NaH2PO4, pH 7.2. This method was effective in
reducing the high abundance protein, albumin, down to levels that would not affect the MS
analysis of plasma HBPs. The diluted supernatant was centrifuged at 5,000 × g for 5 min and
the resulting supernatant was then applied on a 1 mL Hi-Trap heparin column (GE Healthe-
care Life Sciences, capacity 3 mg/mL antithrombin III), equilibrated in modified PBS. The
heparin column was subsequently washed extensively with 50 mL of modified PBS (150 mM
NaCl, 13.7 mM Na2HPO4, 6.3 mM NaH2PO4, pH 7.2). The heparin-bound fraction was then
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eluted with 2 M NaCl in modified PBS and protein quantified by the BCA assay (range 125 μg
to 250 μg).
Protein adsorption using StrataClean for mass spectrometry. In order to eliminate the
high concentration of electrolytes (2.15 M NaCl) in the eluate, so as not to influence MS analy-
sis, StrataClean beads (Agilent Technologies, UK) were used to adsorb proteins [29]. Briefly,
100 μg of the heparin-bound fraction was mixed with 30 μL StrataClean slurry, vortexed for 2
min. and centrifuged at 2,000 × g for 2 min at 4˚C. The supernatant was removed carefully
and discarded. The pellet was first washed with PBS and then further washed twice with H2O.
Sample preparation for mass spectrometry. In the case of plasma samples, the Strata-
Clean beads were resuspended in 80 μL of 25 mM ammonium bicarbonate and 5 μL of 1% (w/
v) Rapigest (Waters, Manchester, UK) added and the samples shaken at 450 rpm for 10 min at
80˚C. Samples were reduced by the addition of 5 μL of 60 mM Dithiothreitol (DTT) and incu-
bated at 60˚C for 10 min and alkylated (addition of 5 μL of 180 mM iodoacetamide and incu-
bation at room temperature for 30 min in the dark). Trypsin (Sigma, Poole, UK, proteomics
grade) was reconstituted in 50 mM acetic acid to a concentration of 0.2 μg/μL and 5 μL (1 μg)
added to the sample followed by overnight incubation at 37˚C. Samples were mixed on a rotat-
ing mixer in overnight at 37˚C.
The following day the digestion was terminated and Rapigest removed by acidification with
TFA (1 μL) and incubation at 37˚C for 45 min. Samples were centrifuged at 17,200 × g for 30
min and the clarified supernatants transferred to tubes.
Mass spectrometry data acquisition and analysis. Data acquisition and analysis were
undertaken similarly with some modifications. Briefly, for LC-MS/MS analysis each digest was
mixed with an equal volume of a protein digest standard (50 fmol/μL yeast enolase, Mass
PREP Digestion Standard, Waters). A 2 μL injection of this mixture, corresponding to 50 fmol
of standard was analysed using an Ultimate 3,000 RSLC nano system (Thermo Scientific,
Hemel Hempstead, U.K.) coupled to a QExactive mass spectrometer (Thermo Scientific). The
sample was loaded onto the trapping column (Thermo Scientific, PepMap100, C18, 300 μm x
5 mm), using partial loop injection, for 7 min at a flow rate of 9 μL/min with 0.1% (v/v) TFA/
2% (v/v) acetonitrile. The sample was resolved on the analytical column (Easy- Spray C18
75 μm x 500 mm 2 μm column) using a gradient of 97% A (0.1% formic acid) 3% B (99.9% ace-
tonitrile, 0.1% formic acid) to 60% A 40% B (all v/v) over 90 min at a flow rate of 300nL/min.
The data-dependent program used for data acquisition consisted of a 70,000 resolution full-
scan MS scan (automatic gain control (AGC) set to 1e6 ions with a maximum fill time of 250
ms) and the 10 most abundant peaks were selected for MS/MS using a 35,000 resolution scan
(AGC set to 1e5 ions with a maximum fill time of 100 ms) with an ion selection window of 2
m/z and a normalised collision energy of 29. To avoid repeated selection of peptides for MS/
MS, the program used a 20 second dynamic exclusion window. The data were processed with
Progenesis QI (version 3 Waters, Newcastle upon Tyne, UK). Samples were automatically
aligned according to retention time. Default peak picking parameters were applied and fea-
tures associated with a peptide ID (charges from 2+ to 7+ in this case) and with three or more
isotope peaks were retained. Database searching was performed using Mascot (Matrix Science,
London, UK). A Mascot Generic File, created by Progenesis QI, was searched against the
reviewed entries of the reference proteome set of M. musculus from Uniprot (23/06/2015,
16,711 sequences) with the sequence of yeast enolase (UniProt: P00924) added. A fixed carba-
midomethyl modification for cysteine and variable oxidation modification for methionine
were specified. A precursor mass tolerance of 10 ppm and a fragment ion mass tolerance of
0.01 Da were applied. The results were then filtered to obtain a peptide FDR of 1%. Label-free
quantification was performed using the “Top3” methodology [20] by the spiking of the sample
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prior to analysis with the internal standard of 50 fmol yeast enolase (UniProt: P00924,
Waters).
Results
Isolation of pancreas HBPs from plasma membrane enriched fractions
from normal pancreas and a murine model of acute pancreatitis
Each extracellular pancreas HBP isolation experiment was performed three times using sixteen
pancreases each from control (NP) and AP mice. Acute pancreatitis was induced in animals by
injection of caerulein. Histological analysis of samples of these pancreases demonstrated the
classic features of normal pancreas with preserved acinar pattern (Fig 1A) and those associated
with AP, namely marked oedema, vacuolisation, neutrophil infiltration in the ductal margins
and parenchyma of the pancreas, with focal acinar cell necrosis (Fig 1B). Serum amylase
increased ~8- to 10-fold in AP compared to NP (Figs 1C and 1D). These data are consistent
with successful induction of AP [30].
Differential centrifugation [31, 32] of pancreas homogenates produced a series of cellular
sub-fractions, including the final microsomal pellet (lane Mc underlined red, Fig 2A and 2B),
which was floated on a sucrose gradient (0.77–1.55 M) to separate its individual constituents
(Fig 2C and 2D). The gradient was harvested into 12 fractions, with the final fraction being dis-
carded. Eleven fractions were assessed by Western blot for the plasma membrane marker
caveolin-1 (Fig 2C and 2D). The caveolin-1 content was inversely correlated with the equilib-
rium density of the sucrose fractions, consistent with their identification as plasma mem-
branes, which possess lower density than other microsomal membranes. Fractions 2 to 4 (Fig
2C and 2D underlined red), which had the strongest caveolin-1 immunoreactivity, were
pooled and selected as the plasma membrane enriched fraction (PM). In addition to mem-
brane-resident proteins, which are often underrepresented in proteomic analyses, this fraction
Fig 1. Normal pancreas (NP) and caerulein-induced acute pancreatitis (AP). Representative images of H&E stained
histology slides of A) NP with intact pancreas architecture and B) AP showing marked oedema, inflammatory cell
infiltration and acinar cell necrosis. Mean serum amylase levels in (C) NP and (D) AP in each experiment consisting of
16 individuals.
https://doi.org/10.1371/journal.pone.0217633.g001
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would also contain intra- and extracellular membrane- associated proteins, as well as proteins
associated with the pericellular matrix.
Fractions 2 to 4 were solubilised in 1% (v/v) Triton-X-100 and subjected to heparin affinity
chromatography. After extensively washing the heparin column with PBS with 0.1% (v/v) Tri-
ton-X-100, proteins that remained bound were deemed to have a sufficiently strong interac-
tion with the polysaccharide to be considered as HBPs. In contrast to previous work [7], here a
single elution at 2 M NaCl with 0.1% (v/v) Triton X-100 was used to recover heparin-binding
proteins. The rationale was that the concentration of NaCl required for elution from heparin
does not necessarily correlate with affinity for HS [33, 34], so fractionating the HBPs does not
necessarily yield useful information.
MS analysis of the pancreas HBPs
Proteins in the 2 M NaCl eluates were precipitated with TCA to remove Triton-X-100, and
then digested with trypsin. After ascertaining the optimal loading concentration, the sample
order was randomised across biological (three each NP and AP) and technical repeats prior to
LC-MS. The LC-MS runs were then individually searched using the MASCOT protein search
engine (www.matrixscience.com). The mass spectrometry proteomics data have been
uploaded into the PRIDE database (http://www.ebi.ac.uk/pride/archive/) [35], via its partner
repository, the ProteomeXchange Consortium [36], with the dataset identifier PXD001950.
There was little variation between the technical replicates for the samples, which can be attrib-
uted to the high quality of the sample preparation and MS analysis (Fig 3). Each technical rep-
licate produced between 1500–1900 protein hits at a peptide FDR of 1%. To obtain a fuller
coverage, the data were run through Progenesis label-free software. The merged file yielded
over 1,900 hits at a peptide FDR of 1%. Using a two-peptide stringency, these were reduced to
1,602 proteins in NP and 1,866 proteins in AP (S1 and S2 Tables).
Fig 2. Preparation of a plasma membrane enriched fraction. Coomassie-stained SDS-PAGE gel of (A) NP and (B)
AP samples obtained during homogenisation and fractionation by sequential steps of centrifugation. Nu = nuclear
pellet; S1 = post-nuclear supernatant; Mt = mitochondrial pellet; S2 = post-mitochondrial supernatant; C = cytosol
(post-microsomal supernatant); W = wash of the microsomal pellet; Mc = microsomal pellet. Coomassie-stained
SDS-PAGE and western blot analysis of 10 fractions (F1-F11) from the microsomal pellet after flotation on a sucrose
gradient (0.25–2 M) in (C) NP and (D) AP. Fractions are ordered depending on their equilibrium density from light
(left) to heavy (right). The enrichment of plasma membrane was assessed by western blot using an antibody against
caveolin-1, which is a specific plasma membrane marker. Full Western blots in S1 Fig.
https://doi.org/10.1371/journal.pone.0217633.g002
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Identification of the extracellular HBPs
The 1,602 proteins in NP and 1,866 proteins in AP were then filtered by the bioinformatics
pipeline described in "Experimental Procedures" to identify those possessing extracellular (par-
tially or wholly) amino acid sequence. Application of this pipeline required in many instances
multiple iterations, because no single approach provided unequivocal evidence for an extracel-
lular location of at least part of the protein sequence. Moreover, a greater confidence was
obtained if more than one tool demonstrated extracellular localization. For example, SignalP
and Phobius identify proteins with signal peptides, which may be secreted extracellularly,
located on the plasma membrane or on an internal cell membrane. Thus secretomeP and IPA
provided both a filter for the output of SignalP and Phobius, as well as identifying new candi-
date extracellular proteins. IPA in particular identified a good many proteins as extracellular
that were not identified as such by these other tools. In all cases information on protein locali-
sation and function was examined in UniprotKB. When only one tool, e.g., IPA indicated
extracellular localisation, confirmation was sought either through UniprotKB and/or the liter-
ature. Filtering the proteins as described above resulted in 320 proteins in NP (S3 Table) and
345 proteins in AP (S4 Table) being identified as heparin binding and extracellular. Combin-
ing these two sets of proteins yielded 440 HBPs, of which 360 had not been identified previ-
ously as heparin binding. With such a substantial number of new HBPs, it was important to
analyse their functions and relationships to gain insight into the significance of the pancreas
and AP associated HBPs.
Label-free quantification
Using the “Top3” methodology, proteins were annotated as differentially expressed between
NP and AP if they achieved a FDR corrected q value of 1% (S5 and S6 Tables). Introduction of
a p value cut off of 0.001, following the Bonferroni correction, resulted in the identification of
79 HBPs that were overexpressed and 48 HBPs that were under expressed significantly in AP,
as compared to NP. Known biomarkers of AP, such as carboxypeptidases (CPB1 and CPB2)
and pancreatic amylase (AMY2A) [17] were overexpressed in the AP group. The top 20 HBPs
Fig 3. Heat map depicting the variation across the biological and technical replicates in extracellular pancreas
HBPs. The rows represent the various biological replicates in normal pancreas (NP) and acute pancreatitis (AP), while
the columns represent proteins. Red represents over expression and green represents under expression. Biological
replicate number is denoted as "BioRep" and technical replicate number as "TechRep". Hierarchical clustering was
performed on both column data, to cluster the changes in protein expression, and row data, which displays the
variation between samples. The stability of the instrument platform is shown in that the lowest branch of the sample
variation dendrogram correctly represents the technical replicates of each sample. The next level of the dendrogram
correctly separates the biological condition of the sample indicating repeatable protein expression differences between
the biological conditions. A higher degree of variability is observed in the AP samples presumably reflecting the
systemic effects of AP.
https://doi.org/10.1371/journal.pone.0217633.g003
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with the highest fold change in each group (Tables 1 and 2) may provide further potential bio-
markers for AP. Some of the most highly expressed HBPs such as neutrophilic granule protein
(NGP) and histidine-rich glycoprotein (HRG) may be representative of the underlying role of
innate immunity in early AP [37–39].
Network construction and analysis of HBPs in the pancreas
The lists of HBPs in NP and AP were used to obtain protein-protein interactions (PPI) from
STRING. Only interactions with a high confidence score (0.70 and above) were used to con-
struct extracellular heparin-binding protein interactomes in NP (Fig 4) and AP (Fig 5). The
topological parameters of the HBP interactomes were obtained from STRING 10.5. The extra-
cellular HBP interactomes of NP and AP have high clustering coefficients (NP = 0.364 and
AP = 0.435), which were also significantly higher than those of their corresponding random
networks. The PPI enrichment p-values for both extracellular pancreas HBP interactomes
were< 1.0e-16. These findings suggest that the HBP interactomes form highly interconnected
modules [27, 40] in the extracellular space of the pancreas. Such high connectivity generally
reflects a high capacity for regulation. This would mean that the extracellular HBP interac-
tomes are likely to be important in homeostasis of the normal pancreas and the HBPs identi-
fied in AP may have key roles in mediating the altered cell communication that is associated
with the disease.
Analysis of Canonical Pathways, Bio-functions of pancreas HBPs in NP
and AP
The functional context of a particular HBP with respect to the other HBPs will be important,
particularly since these proteins are highly interconnected. HBPs in NP and AP clearly have
Table 1. Top 20 extracellular pancreas HBPs overexpressed in AP. The upregulated HBPs were filtered depending
on the maximum fold change values. An adjusted threshold p value of less than 0.001 following the Bonferroni correc-
tion was used to identify the top HBPs to be validated as potential biomarkers.
HBP Max fold change
CPB2 89
Ngp 78
HRG 76
PRSS3 57
SERPINC1 43
ITIH2 43
PLG 42
COL6A3 41
SERPIND1 36
CTRC 36
FN1 35
AHSG 30
SERPINA1 27
COL1A2 25
PRG2 23
SERPINA3 20
F2 20
Ear3 19
CPB1 17
https://doi.org/10.1371/journal.pone.0217633.t001
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functions important in cell communication and they are enriched in a number of canonical
pathways (Tables 3 and 4, S7 and S8 Tables) underlying homeostasis and complex diseases,
both at a systemic and an organ / disease level (NP and AP). For example, the top canonical
pathway associated with the NP dataset, ‘Signalling by Rho Family GTPases’ plays an impor-
tant role in cell adhesion, as do a number of the other highly ranked pathways, ’RhoGDI Sig-
naling’, ’Ephrin B Signaling’, ’Tec Kinase Signaling’, ’Actin Cytoskeleton Signaling’ and
’Ephrin Receptor Signaling’. Cell adhesion is essential to the maintenance of tissue architecture
and so cell communication appropriate for homeostasis [41]. In contrast, the top pathways
associated with the HBPs in AP are associated with inflammatory responses. Thus, the top
four pathways in AP are ‘Coagulation System’, ‘Acute Phase Response Signalling’, ‘Intrinsic
Prothrombin Activation Pathway’ and ‘LXR/RXR Activation’). The presence of pathways
linked to cell adhesion further down the list (’Actin Cytoskeleton Signaling’, ’RhoGDI Signal-
ing’, ’Signaling by Rho Family GTPases’, ’Ephrin Receptor Signaling’, ’Ephrin B Signaling’ and
’Integrin Signaling’), would then reflect the predominance of cell motility and a change in tis-
sue architecture, driven by the inflammatory pathways. Analysis of the bio-functions associ-
ated with the HBPs in NP (S9 Table) and AP (S10 Table) support the conclusions reached
from the analysis of canonical pathways.
Plasma HBPs
Identification of the plasma HBPs. Each plasma HBP isolation experiment was per-
formed three times using blood obtained by cardiac puncture from control (NP) and AP mice.
Acute pancreatitis was induced in animals as described previously. Histological and biochemi-
cal confirmation was consistent with the successful induction of AP (S2 Fig).
Table 2. Top 20 extracellular pancreas HBPs underexpressed in AP. The downregulated HBPs were filtered
depending on the maximum fold change values. An adjusted threshold p value of less than 0.001 following the Bonfer-
roni correction was used to identify the top HBPs to be validated as potential biomarkers.
HBP Max fold change
SLC4A7 -13
SLC4A2 -10
KCNQ1 -10
TFRC -8
CLPS -7
CLTB -7
CNNM2 -5
SLC7A1 -5
SIDT2 -4
CCKAR -3
MPP7 -3
CCDC93 -3
VAMP2 -3
ATP11C -3
SLC38A3 -3
SNTB1 -3
SLC9A3R2 -3
SLC7A2 -3
VAMP3 -3
SLC4A7 -13
https://doi.org/10.1371/journal.pone.0217633.t002
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The high abundance of serum albumin can pose problems for the analysis of plasma pro-
teins by mass spectrometry. However, this protein does not bind heparin in the presence of
electrolytes. To ensure initial binding of HBPs from plasma to heparin, the sample was applied
to the heparin column in the lowest electrolyte concentration that prevented serum albumin
binding. Thus, the citrated murine plasma was diluted with a PBS (150 mM NaCl) that was
itself diluted with H2O to reduce the NaCl concentration to 75 mM. This was effective in
reducing the albumin levels significantly in the eluate from the heparin column (S3 Fig) and
subsequent washing of the heparin column with PBS ensured that proteins bound heparin at
physiologically relevant electrolyte concentrations. Thus, heparin affinity chromatography is a
useful means to remove serum albumin from plasma samples, facilitating the MS analysis of
plasma. Analysis of the MS data identified 161 plasma HBPs in NP (S11 Table) and 151 plasma
HBPs in AP (S12 Table).
Label-free quantification. Label-free quantification was performed following the “Top3”
methodology, as previously described (Fig 6). This identified 69 HBPs that were overexpressed
(S13 Table), which included known biomarkers of AP such as serum amyloid A (SAA) as well
as emerging novel markers and drug targets in AP such as histone H2A (Table 5), and 81 that
were underexpressed (S14 Table) in AP. Interestingly, HRG, which was overexpressed in the
pancreas in AP, was underexpressed in plasma in AP.
Discussion
HBPs are functionally associated with the regulation of cell communication that underlies
many physiological and pathological processes. AP represents a disease with unmet clinical
need from the perspective of prognosis and treatment, particularly with respect to progression
to severe AP, which can be life-threatening. Encouraged by the initial work using mRNA as a
proxy for pancreas HBPs [13], we, therefore, determined whether there were changes in the
levels of HBPs associated with AP in the murine caerulein model of the disease. One focus was
on extracellular HBPs of the pancreas itself. Only extracellular HBPs were considered, because,
whilst there is clear evidence for intracellular HS [42–44], there is no means at present to dis-
tinguish in a proteomic experiment intracellular proteins that interact with intracellular HS
from those that natively interact solely with another intracellular polyanion, such as
Fig 4. The heparin-binding putative protein interactome in normal pancreas (NP) constructed using STRING
10.5. Nodes or HBPs are connected by protein-protein interactions known as ‘edges’.
https://doi.org/10.1371/journal.pone.0217633.g004
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phosphorylated lipids and nucleic acids. The present analysis aimed to identify disease-related
HBPs, and so processes, some of which may be potential therapeutic targets. However, poten-
tial biomarkers need to be more accessible, as sampling the pancreas is invasive, so plasma
HBPs were also analysed. In this instance, because plasma is by definition cell-free, potentially
intracellular proteins were also of interest. Moreover, the presence of exosome-associated pro-
teins (S3, S4, S11 & S12 Tables) is consistent with at least a subset of these vesicles binding hep-
arin [45–47].
A number of tools were used to identify pancreas HBPs with significant amino acid
sequence in the extracellular space, including SignalP, Phobius, SecretomeP, IPA, and manual
curation for the presence of an extracellular signature using Uniprot-KB and PubMed. In a
previous analysis of rat liver a bioinformatics pipeline based on ontology (gene ontology and
ingenuity ontology, IPA) was combined with manual curation to identify 62 HBPs, of which
12 were previously known to bind to heparin [7]. Middaugh and coworkers employing an anti-
body array on total cell lysate before and after depletion of HBPs by heparin agarose beads,
Fig 5. The heparin-binding putative protein interactome in acute pancreatitis (AP) constructed using STRING
10.5. Nodes or HBPs are connected by protein-protein interactions known as ‘edges’.
https://doi.org/10.1371/journal.pone.0217633.g005
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identified 29 proteins whose signal was significantly reduced after incubation of the cell lysate
with heparin beads, though only three were extracellular [48]. Our present approach identified
360 new extracellular HBPs that were not previously known to bind the polysaccharide [7].
While plasma provides a rich and accessible repository of proteins, the large dynamic range
of protein concentrations and high abundance proteins such as albumin pose a significant
challenge to effective protein discovery [49, 50]. However, albumin does not bind heparin in
the presence of electrolytes and to ensure initial binding of HBPs from plasma to heparin, the
sample was applied to the heparin column in the lowest electrolyte concentration that pre-
vented serum albumin binding. In addition to extracellular/secreted proteins, a number of
nuclear proteins such as histone H2A, cytoplasmic proteins such as FERMT3 (fermitin family
member 3) and endoplasmic reticulum proteins such as HSPA5 (heat shock protein A5) were
also detected in plasma.
An important question is how representative are the HBPs identified here of the proteins in
NP and AP whose function depends on, or is modified by, interaction with HS. The mass spec-
trometry is limited by the depth of the analysis and only accepting identifications based on at
least two peptides and a maximum false discovery rate of 1%. This in itself leads to false posi-
tives and false negatives. To reduce further the number of false positives for the purpose of bio-
marker identification, stringency was increased by using the Bonferroni correction [21].
Mascot (Matrix Science, London, UK) uses peptide FDR for protein identification instead of
protein FDR. Mascot’s essential point of rejection of protein FDR is that because proteins
share sequences, normally a parsimonious list is presented (if a unique peptide is found to a
member of the group, then all shared peptides are also assigned to this member and the
remaining group members are said to be not present), which might actually be an incorrect
Table 3. Top 20 canonical pathways enriched to extracellular pancreas HBPs in NP using ingenuity pathways
analysis. The significance of the association between the datasets and the canonical pathway was measured by calculat-
ing the p-value using Fisher’s exact test to determine the probability of the association between the HBPs in the dataset
and the canonical pathway.
Canonical Pathways -log (p-value)
Signaling by Rho Family GTPases 11.1
RhoGDI Signaling 10.1
CXCR4 Signaling 9.55
G Beta Gamma Signaling 8.76
Thrombin Signaling 8.25
IL-1 Signaling 8.15
Role of NFAT in Regulation of the Immune Response 7.98
Tec Kinase Signaling 7.75
Clathrin-mediated Endocytosis Signaling 7.67
Caveolar-mediated Endocytosis Signaling 7.23
Ephrin B Signaling 7.11
Actin Cytoskeleton Signaling 6.86
Role of Tissue Factor in Cancer 6.8
Cardiac Hypertrophy Signaling 6.51
Integrin Signaling 6.38
Relaxin Signaling 6.25
Gαi Signaling 5.97
Ephrin Receptor Signaling 5.94
CREB Signaling in Neurons 5.63
Tight Junction Signaling 5.45
https://doi.org/10.1371/journal.pone.0217633.t003
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assumption. It therefore becomes very difficult to present an accurate list of proteins, even
though one can be accurate with the peptides that are present [51]. There are additional factors
that are likely to contribute to the false positives and false negatives. Some HBPs may escape
detection, because they are part of large macromolecular assemblies that are not solubilised by
Triton-X-100, associated with, for example, matrix fibrils, membrane microdomains or cyto-
skeleton. Moreover, not all HS-binding proteins will necessarily bind the heparin column and
may instead remain bound to HS proteoglycans during affinity chromatography. Indeed, the
transition and S-domains of HS have far more diverse structures than heparin [8, 9]. Thus, the
present analysis will have a bias towards HBPs that bind structures present in the trisulfated
disaccharide repeat of heparin, which makes up 75% of the polysaccharide and contains 2-O
sulfated iduronate, N-, 6-O sulfated glucosamine. A source of false positives would be proteins
that do not bind HS, but are bound to an HBP with a sufficiently slow dissociation rate con-
stant that they would be carried though the affinity chromatography, an interaction that would
be consistent with biological function. Apart from the limits imposed on the mass spectrome-
try analysis, the other sources of false positives and negatives are not currently quantifiable,
until such time as the interaction of each HBP with the polysaccharide is measured directly.
A recurrent question is how specific or selective is a protein-HS interaction [8, 9]. This will
be important in terms of understanding the mechanism whereby HS regulates the activity of a
protein. HS has been shown to directly control the movement of a protein, fibroblast growth
factor-2 in the pericellular matrix [52]. Thus, regardless of specificity and selectivity of the
interaction of a protein with HS, this will restrict the movement of the protein in the extracel-
lular space and so affect its function in terms of location and local concentration. Therefore,
proteins that bind heparin in PBS and that remain bound during the extensive washing of the
Table 4. Top 20 canonical pathways enriched to extracellular pancreas HBPs in experimental AP using ingenuity
pathways analysis. The significance of the association between the datasets and the canonical pathway was measured
by calculating the p-value using Fisher’s exact test to determine the probability of the association between the HBPs in
the dataset and the canonical pathway.
Canonical Pathways -log (p-value)
Coagulation System 14.9
Acute Phase Response Signaling 14
Intrinsic Prothrombin Activation Pathway 13.6
LXR/RXR Activation 13.4
FXR/RXR Activation 11.8
Clathrin-mediated Endocytosis Signaling 11.6
Extrinsic Prothrombin Activation Pathway 10.1
Complement System 9.89
Actin Cytoskeleton Signaling 9.64
RhoGDI Signaling 9.63
G Beta Gamma Signaling 9.38
Role of Tissue Factor in Cancer 9.33
Ephrin Receptor Signaling 8.93
Signaling by Rho Family GTPases 8.91
Integrin Signaling 8.34
CXCR4 Signaling 8.24
Ephrin B Signaling 7.93
Virus Entry via Endocytic Pathways 7.21
Thrombin Signaling 7.05
Caveolar-mediated Endocytosis Signaling 6.97
https://doi.org/10.1371/journal.pone.0217633.t004
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affinity column have a relatively slow dissociation rate constant and would be expected to have
at least their movement and extracellular location regulated by HS. Taking into account the
caveats described above regarding false positives, the HBPs identified here are thus likely to
have at least this aspect of their function regulated in this way by HS in the extracellular space
of NP and AP. Any changes in the structure of HS that might accompany AP may, therefore,
alter the movement of the HBP and so its contribution to cell physiology.
Thus, the heparin interactome is now substantially larger than previously described [7].
Importantly, the protein-protein interaction network of the HBPs retains the key properties of
the earlier, smaller interactome and hence its functional relevance to the regulation of cell
Fig 6. Heat map depicting the variation across the biological and technical replicates in plasma HBPs. The rows
represent the various biological replicates from plasma in health (NP) and acute pancreatitis (AP), while the columns
represent proteins. Red represents over expression and green represents under expression. Biological replicate number
is denoted as "BioRep" and technical replicate number as "TechRep". Hierarchical clustering was performed on both
column data, to cluster the changes in protein expression, and row data, which displays the variation between samples.
https://doi.org/10.1371/journal.pone.0217633.g006
Table 5. Top 20 plasma HBPs overexpressed in AP. The upregulated HBPs were filtered depending on the maxi-
mum fold change values.
Plasma HBP Max fold change
SAA1 141
Svs4 70
HP 15
LBP 6
TNNI3 4
Ngp 3
TNNT2 3
ITIH4 2
H2AFZ 2
Prg4 2
https://doi.org/10.1371/journal.pone.0217633.t005
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communication by extracellular proteins [7]. Thus, the HBP interactome is highly intercon-
nected and HBPs form numerous regulatory modules in the extracellular space. Importantly,
this is true for the subset of HBPs expressed by a single organ, the pancreas and one of its asso-
ciated diseases, AP. Thus, it may be that for most if not all organs, HBPs represent a highly
interconnected set of extracellular proteins, which have significant regulatory potential.
This work has identified a range of changes that provide deeper insight into known mecha-
nisms in AP. A number of biomarkers that have been previously investigated in AP, such as
carboxypeptidase B and pancreatic amylase, are amongst the HBPs that exhibited a significant
increase in the extracellular pancreas AP dataset (Table 1 and S5 Table). Others such as SAA1
are significantly overexpressed in plasma in AP [53]. Some of the most highly expressed pan-
creas HBPs such as NGP and HRG are representative of the underlying role of innate immu-
nity in early AP. NGP overexpression indicates the early presence of neutrophils in AP [54],
which have been shown to play an important role in AP [37]. Neutrophil extracellular traps
(NETs) are composed of extracellular DNA, neutrophil-derived granule proteins, and histones
and are produced in AP as well as play a critical role in its development [55]. HRG is an impor-
tant mediator of macrophage clearance of apoptotic cells [38] and plays important roles in the
adhesion and spread of activated T-cells [39]. In contrast to its elevated levels in the pancreas,
HRG is underexpressed in plasma in AP. Histone H2A levels were significantly increased in
plasma in AP. The quantitative assessment of histones in plasma has been demonstrated to
accurately predict persistent organ failure and mortality in AP [56]. Thus, the HBPs exhibiting
the greatest fold change (Table 1) alone or in combination with existing biomarkers may pro-
vide an improved clinical stratification of the severity of AP. Others such as serpin peptidase
inhibitor, clade C (antithrombin), member 1 (SERPINC1) have anti-inflammatory properties
and have been shown to improve acute pancreatitis in the rat model [57] and may be explored
in drug development in AP. Some of the HBPs that are underexpressed in AP may point to a
possible disturbance in the homeostatic mechanisms underlying AP. The underexpression of
SLC4A7, KCNQ1 and VAMP2 (Table 2) are indicative of the impaired cellular trafficking of
electrolytes that accompanies AP. In addition to its important role in K+ homeostasis, KCNQ1
also influences hormone transport [58].
CXCR4 signalling regulates cell differentiation, cell chemotaxis, cell survival and apoptosis,
and has important roles in the embryonic development of the pancreas [59]. Its importance as
a key canonical pathway in AP is supported by the identification of its protective role in AP,
which may be mediated by facilitating the migration of bone marrow derived stem cells
towards the pancreas [60]. Early activation of the ‘Complement system’, a pathway enriched to
the extracellular pancreas HBPs in AP, occurs in pancreatic necrosis and corresponds to the
overexpression of various proteins of the complement system in the plasma in AP, which sug-
gests that this pathway may enable the development of treatment of leukocyte-associated
injury in AP [61]. In this respect, non-anticoagulant heparin-based compounds [62] might be
particularly interesting as potential therapeutics for AP. They may be tuneable to modulate a
gamut of HBPs important in the cell communication underlying the progression of AP, which
could include complement system activation, growth factors and cytokines, and, because hepa-
rin can modulate the activity of some transporters [63], then metabolism.
The HBPs define a group of proteins that have clear functional importance in cell commu-
nication, homeostasis and at least one disease, AP. HBPs are experimentally accessible, because
they bind to heparin and are extracellular, and in at least some instances are present in serum.
Therefore the HBPs of the pancreas and AP may yield much-needed biomarkers and targets
for therapy, a conclusion reinforced by the observation that HBPs identify through their func-
tions to known mechanisms of AP and current targets for therapy in AP and other diseases.
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Supporting information
S1 Fig. Full western blots. The enrichment of plasma membrane was assessed by western blot
using an antibody against caveolin-1, which is a specific plasma membrane marker in (A) NP
and (B) AP.
(TIF)
S2 Fig. Normal pancreas (NP) and caerulein-induced acute pancreatitis (AP) in the plasma
HBP experiment. Representative images of H&E stained histology slides of A) NP with intact
pancreas architecture and B) AP showing marked oedema, inflammatory cell infiltration and
acinar cell necrosis. Mean serum amylase levels in (C) NP and AP.
(TIF)
S3 Fig. Plasma heparin binding proteins isolated using heparin affinity chromatography
in NP. Murine plasma was diluted in PBS (1:8), and loaded onto a heparin column. The col-
umn was washed with PBS and further eluted using 2.15 M NaCl. Supernatant pre-loading
onto the heparin column and the flow through were also examined and revealed that albumin
levels decreased to negligible levels in the sample, which made effective MS analysis feasible.
(TIF)
S4 Fig. SDS-PAGE following heparin affinity chromatography and StractaClean adsorp-
tion. Following elution off the heparin column using 2.15 M NaCl (lane HBPs pre-Strata-
Clean), ~100 μg was adsorbed onto 30 μL of StrataClean (Agilent Technologies). The
supernatant (lane post-StrataClean supernatant) was removed after vortexing for 2 min and
centrifugation at 2,000 × g. StrataClean resin was then washed with PBS and spun down (lane
post-StrataClean PBS wash). The pellet was finally resupended in 170 μL H2O, 150 μL for
mass spectrometry (MS), and the rest (approx. 20 μL) was resuspended with 10 μL of
2 × Laemmlli buffer and boiled for 5 min (lane HBPs post-StrataClean). Samples were loaded
onto 12% SDS-PAGE and stained using silver staining.
(TIF)
S1 Table. Proteins in normal pancreas (NP) using a two-peptide stringency. Each technical
replicate produced between 1500–1900 protein hits at a peptide FDR of 1%. To obtain a fuller
coverage, the data were run through Progenesis label-free software. The merged file yielded
over 1,900 hits at a peptide FDR of 1%. Using a two-peptide stringency, these were reduced to
1,602 proteins in NP.
(XLS)
S2 Table. Proteins in acute pancreatitis (AP) using a two-peptide stringency. Each technical
replicate produced between 1500–1900 protein hits at a peptide FDR of 1%. To obtain a fuller
coverage, the data were run through Progenesis label-free software. The merged file yielded
over 1,900 hits at a peptide FDR of 1%. Using a two-peptide stringency, these were reduced to
1,866 proteins in AP.
(XLS)
S3 Table. Pancreas extracellular HBPs in normal pancreas (NP). Filtering the proteins using
a bioinformatics pipeline resulted in 320 proteins in NP.
(XLS)
S4 Table. Pancreas extracellular HBPs in acute pancreatitis (AP). Filtering the proteins
using a bioinformatics pipeline resulted in 345 proteins in AP.
(XLS)
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S5 Table. Overexpressed pancreas extracellular HBPs in acute pancreatitis (AP). Using the
“Top3” methodology, proteins were annotated as differentially expressed between NP and AP
if they achieved a FDR corrected q value of 1%. Introduction of a p value cut off of 0.001, fol-
lowing the Bonferroni correction, resulted in the identification of 79 HBPs that were overex-
pressed in AP, as compared to NP.
(XLS)
S6 Table. Underexpressed pancreas extracellular HBPs in acute pancreatitis (AP). Using
the “Top3” methodology, proteins were annotated as differentially expressed between NP and
AP if they achieved a FDR corrected q value of 1%. Introduction of a p value cut off of 0.001,
following the Bonferroni correction, resulted in the identification of 48 HBPs that were under
expressed significantly in AP, as compared to NP.
(XLS)
S7 Table. Canonical pathways associated with pancreas extracellular HBPs in normal pan-
creas (NP). The top canonical pathways associated with the NP dataset relate to tissue homeo-
stasis.
(XLS)
S8 Table. Canonical pathways associated with pancreas extracellular HBPs in acute pan-
creatitis (AP). The top pathways associated with the HBPs in AP relate to inflammatory
responses.
(XLS)
S9 Table. Diseases and functions associated with pancreas extracellular HBPs in normal
pancreas (NP). The top diseases and functions associated with the NP dataset relate to tissue
homeostasis.
(XLS)
S10 Table. Diseases and functions associated with pancreas extracellular HBPs in acute
pancreatitis (AP). The top diseases and functions associated with the HBPs in AP relate to
inflammatory responses.
(XLS)
S11 Table. Plasma HBPs in normal pancreas (NP). Analysis of the MS data identified 161
plasma HBPs in NP.
(XLS)
S12 Table. AP Plasma HBPs in acute pancreatitis (AP). Analysis of the MS data identified
151 plasma HBPs in AP.
(XLS)
S13 Table. Overexpressed plasma HBPs in acute pancreatitis (AP). Label-free quantification
following the “Top3” methodology identified 69 plasma HBPs that were overexpressed in AP.
(XLS)
S14 Table. Underexpressed plasma HBPs in acute pancreatitis (AP). Label-free quantifica-
tion following the “Top3” methodology identified 81 that were underexpressed in AP.
(XLS)
S15 Table. New global list of extracellular HBPs. The total number of HBPs has increased to
786, further to this study.
(XLS)
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